A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial Cancer
Clinical trial NCT05754853 · RECRUITING
Trial details
- NCT number
- NCT05754853
- Sponsor
- Shanghai Miracogen Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-06
- Primary completion
- 2025-10-01
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.